Pulmonary disease as a risk factor for transfusion-related acute lung injury in hospitalized patients: a nested case-control study in Japan

Author(s):  
Akira Yokoyama ◽  
Yukiyo Sakamoto ◽  
Jo Taisuke ◽  
Hirokazu Urushiyama ◽  
Hiroyuki Tamiya ◽  
...  
Thorax ◽  
2009 ◽  
Vol 64 (2) ◽  
pp. 121-127 ◽  
Author(s):  
E R Fernandez-Perez ◽  
J Sprung ◽  
B Afessa ◽  
D O Warner ◽  
C M Vachon ◽  
...  

2010 ◽  
Vol 38 (3) ◽  
pp. 771-778 ◽  
Author(s):  
Alexander P. J. Vlaar ◽  
Jan M. Binnekade ◽  
David Prins ◽  
Danielle van Stein ◽  
Jorrit J. Hofstra ◽  
...  

2008 ◽  
Vol 89 (11) ◽  
pp. 2882-2890 ◽  
Author(s):  
Zhong-Liao Fang ◽  
Caroline A. Sabin ◽  
Bai-Qing Dong ◽  
Shao-Chao Wei ◽  
Qin-Yan Chen ◽  
...  

A matched nested case–control study of 33 paired cases and controls was conducted, based on a study cohort in Long An county, Guangxi, China, to determine whether infection with hepatitis B virus (HBV) with pre-S deletions is independently associated with the development of hepatocellular carcinoma (HCC), without the confounding effects of basal core promoter (BCP) double mutations. The prevalence of pre-S deletions was significantly higher in HCC (45.5 %, 15 of 33) than the controls (18.2 %, 6 of 33) (P<0.01), under the control of the influence of BCP double mutations. Most of the pre-S deletions occurred in, or involved, the 5′ half of the pre-S2 region and the difference between HCC (93.3 %, 14 of 15) and controls (66.7 %, four of six) was significant for this region (P=0.015). There was no significant difference in pre-S deletions between the BCP mutant group and BCP wild-type group (P>0.05), nor was the prevalence of pre-S deletions significantly different between genotypes B and C (P>0.1). These results suggest that pre-S deletions constitute an independent risk factor for HCC and their emergence and effect are independent of BCP mutations. The 5′ terminus of pre-S2 is the favoured site for the deletion mutations, especially in HCC cases. Further prospective studies are required to confirm the role of these mutations in the development of HCC.


2020 ◽  
Vol Volume 15 ◽  
pp. 2799-2806
Author(s):  
Jesús Díez-Manglano ◽  
María Berges Vidal ◽  
Lucía Martínez Barredo ◽  
Beatriz Poblador-Plou ◽  
Antonio Gimeno-Miguel ◽  
...  

2002 ◽  
Vol 18 (1) ◽  
pp. 45-53 ◽  
Author(s):  
A. Karakatsani ◽  
S. Andreadaki ◽  
K. Katsouyanni ◽  
I. Dimitroulis ◽  
D. Trichopoulos ◽  
...  

2011 ◽  
Vol 9 (1) ◽  
pp. 71-78 ◽  
Author(s):  
L. M. HILTUNEN ◽  
H. LAIVUORI ◽  
A. RAUTANEN ◽  
R. KAAJA ◽  
J. KERE ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document